Top

Published in:

01-12-2021 | Ovarian Cancer | Original Article

Differential Expression and Copy Number Variation of Gasdermin (GSDM) Family Members, Pore-Forming Proteins in Pyroptosis, in Normal and Malignant Serous Ovarian Tissue

Authors: Caglar Berkel, Ercan Cacan

Published in: Inflammation | Issue 6/2021

Abstract

Gasdermins (GSDM) are members of a family of pore-forming effector proteins which lead to membrane permeabilization and pyroptosis, a lytic cell death with pro-inflammatory characteristics. Recently, two members of the gasdermin family, gasdermin B (GSDMB) and gasdermin E (GSDME), were shown to suppress tumor growth, through the involvement of cytotoxic lymphocytes. Other studies also reported the important functions of gasdermins in various cancer types including gastric cancer, hepatocarcinoma, and cervix and breast cancer. However, gasdermins have not been previously studied in the context of serous ovarian cancer. Here, we showed that gasdermin D (GSDMD) and gasdermin C (GSDMC) expression increases in serous ovarian cancer; in contrast, the expression of GSDME and PJVK (Pejvakin, DFNB59) is downregulated, compared to healthy ovaries, in multiple independent gene expression datasets. We found that copy number gains are highly frequent (present in approximately 50% of patients) in genes encoding GSDMD and GSDMC in ovarian cancer, in line with their upregulated expression in serous ovarian cancer. Moreover, we observed that the expression of GSDMB and GSDMD, but not of GSDME, is different among several histotypes of epithelial ovarian cancer. Therefore, we propose that differential expression and copy number variations of certain gasdermins might be associated with the development of serous ovarian cancer, in which different members of the family have distinct functions; however, further research is required in in vivo models to understand how changes in gasdermin family members mechanistically contribute to serous ovarian cancer.

Available only for authorised users

Ferlay, J., I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D.M. Parkin, D. Forman, and F. Bray. 2015 Mar 1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136 (5): E359–E386. https://doi.org/10.1002/ijc.29210.CrossRefPubMed

Berkel, C., and E. Cacan. 2021. Transcriptomic analysis reveals tumor stage- or grade-dependent expression of miRNAs in serous ovarian cancer. Hum Cell. 34: 862–877. https://doi.org/10.1007/s13577-021-00486-3.CrossRefPubMed

Bristow, R.E., R.S. Tomacruz, D.K. Armstrong, E.L. Trimble, and F.J. Montz. 2002 Mar 1. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 20 (5): 1248–1259. https://doi.org/10.1200/JCO.2002.20.5.1248.CrossRefPubMed

Kyrgiou, M., G. Salanti, N. Pavlidis, E. Paraskevaidis, and J.P. Ioannidis. 2006. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments. J Natl Cancer Inst. 98 (22): 1655–1663. https://doi.org/10.1093/jnci/djj443.CrossRefPubMed

Coukos, G., J. Tanyi, and L.E. Kandalaft. 2016. Opportunities in immunotherapy of ovarian cancer. Ann Oncol (Suppl 1): i11–i15. https://doi.org/10.1093/annonc/mdw084 PMID: 27141063; PMCID: PMC4852275.

Drake, C.G., E.J. Lipson, and J.R. Brahmer. 2014. Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer. Nat Rev Clin Oncol (1): 24–37. https://doi.org/10.1038/nrclinonc.2013.208 Epub 2013 Nov 19. PMID: 24247168; PMCID: PMC4086654.

Kayagaki, N., I.B. Stowe, B.L. Lee, K. O’Rourke, K. Anderson, S. Warming, T. Cuellar, B. Haley, M. Roose-Girma, Q.T. Phung, P.S. Liu, J.R. Lill, H. Li, J. Wu, S. Kummerfeld, J. Zhang, W.P. Lee, S.J. Snipas, G.S. Salvesen, L.X. Morris, L. Fitzgerald, Y. Zhang, E.M. Bertram, C.C. Goodnow, and V.M. Dixit. 2015 Oct 29. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 526 (7575): 666–671. https://doi.org/10.1038/nature15541.CrossRefPubMed

Shi, J., Y. Zhao, K. Wang, X. Shi, Y. Wang, H. Huang, Y. Zhuang, T. Cai, F. Wang, and F. Shao. 2015 Oct 29. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 526 (7575): 660–665. https://doi.org/10.1038/nature15514.CrossRefPubMed

He, W.T., H. Wan, L. Hu, P. Chen, X. Wang, Z. Huang, Z.H. Yang, C.Q. Zhong, and J. Han. 2015. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res (12): 1285–1298. https://doi.org/10.1038/cr.2015.139 Epub 2015 Nov 27. PMID: 26611636; PMCID: PMC4670995.

10.

Broz, P., P. Pelegrín, and F. Shao. 2020 Mar. The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 20 (3): 143–157. https://doi.org/10.1038/s41577-019-0228-2.CrossRefPubMed

11.

Ding, J., K. Wang, W. Liu, Y. She, Q. Sun, J. Shi, H. Sun, D.C. Wang, and F. Shao. 2016. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535 (7610): 111–116. https://doi.org/10.1038/nature18590 Epub 2016 Jun 8. Erratum in: Nature. 2016 Dec 1;540(7631):150.CrossRefPubMed

12.

Aglietti, R.A., A. Estevez, A. Gupta, M.G. Ramirez, P.S. Liu, N. Kayagaki, C. Ciferri, V.M. Dixit, and E.C. Dueber. 2016. GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes. Proc Natl Acad Sci U S A 113 (28): 7858–7863. https://doi.org/10.1073/pnas.1607769113 Epub 2016 Jun 23. PMID: 27339137; PMCID: PMC4948338.CrossRefPubMedPubMedCentral

13.

Liu, X., Z. Zhang, J. Ruan, Y. Pan, V.G. Magupalli, H. Wu, and J. Lieberman. 2016. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535 (7610): 153–158. https://doi.org/10.1038/nature18629 PMID: 27383986; PMCID: PMC5539988.CrossRefPubMedPubMedCentral

14.

Sborgi L, Rühl S, Mulvihill E, Pipercevic J, Heilig R, Stahlberg H, Farady CJ, Müller DJ, Broz P, Hiller S. GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO J. 2016 Aug 15;35(16):1766-78. doi: 10.15252/embj.201694696. Epub 2016 Jul 14. PMID: 27418190; PMCID: PMC5010048.

15.

Demarco B, Grayczyk JP, Bjanes E, Le Roy D, Tonnus W, Assenmacher CA, Radaelli E, Fettrelet T, Mack V, Linkermann A, Roger T, Brodsky IE, Chen KW, Broz P. Caspase-8-dependent gasdermin D cleavage promotes antimicrobial defense but confers susceptibility to TNF-induced lethality. Sci Adv. 2020 Nov 18;6(47):eabc3465. doi: https://doi.org/10.1126/sciadv.abc3465. PMID: 33208362; PMCID: PMC7673803.

16.

Chen KW, Demarco B, Heilig R, Shkarina K, Boettcher A, Farady CJ, Pelczar P, Broz P. Extrinsic and intrinsic apoptosis activate pannexin-1 to drive NLRP3 inflammasome assembly. EMBO J. 2019 May 15;38(10):e101638. doi: https://doi.org/10.15252/embj.2019101638. Epub 2019 Mar 22. PMID: 30902848; PMCID: PMC6517827.

17.

Orning P, Weng D, Starheim K, Ratner D, Best Z, Lee B, Brooks A, Xia S, Wu H, Kelliher MA, Berger SB, Gough PJ, Bertin J, Proulx MM, Goguen JD, Kayagaki N, Fitzgerald KA, Lien E. Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death. Science. 2018 Nov 30;362(6418):1064-1069. doi: https://doi.org/10.1126/science.aau2818. Epub 2018 Oct 25. PMID: 30361383; PMCID: PMC6522129.

18.

Sarhan J, Liu BC, Muendlein HI, Li P, Nilson R, Tang AY, Rongvaux A, Bunnell SC, Shao F, Green DR, Poltorak A. Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection. Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):E10888-E10897. doi: https://doi.org/10.1073/pnas.1809548115. Epub 2018 Oct 31. PMID: 30381458; PMCID: PMC6243247.

19.

Sanjo, H., J. Nakayama, T. Yoshizawa, H.J. Fehling, S. Akira, and S. Taki. 2019 Aug 15. Cutting edge: TAK1 safeguards macrophages against proinflammatory cell death. J Immunol. 203 (4): 783–788. https://doi.org/10.4049/jimmunol.1900202.CrossRefPubMed

20.

Wang, Y., W. Gao, X. Shi, J. Ding, W. Liu, H. He, K. Wang, and F. Shao. 2017 Jul 6. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 547 (7661): 99–103. https://doi.org/10.1038/nature22393.CrossRefPubMed

21.

Rogers C, Fernandes-Alnemri T, Mayes L, Alnemri D, Cingolani G, Alnemri ES. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death. Nat Commun. 2017 Jan 3;8:14128. doi: https://doi.org/10.1038/ncomms14128. PMID: 28045099; PMCID: PMC5216131.

22.

Hou J, Zhao R, Xia W, Chang CW, You Y, Hsu JM, Nie L, Chen Y, Wang YC, Liu C, Wang WJ, Wu Y, Ke B, Hsu JL, Huang K, Ye Z, Yang Y, Xia X, Li Y, Li CW, Shao B, Tainer JA, Hung MC. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nat Cell Biol. 2020 Oct;22(10):1264-1275. doi: https://doi.org/10.1038/s41556-020-0575-z. Epub 2020 Sep 14. Erratum in: Nat Cell Biol. 2020 Nov;22(11):1396. PMID: 32929201; PMCID: PMC7653546.

23.

Saeki, N., Y. Kuwahara, H. Sasaki, H. Satoh, and T. Shiroishi. 2000 Sep. Gasdermin (Gsdm) localizing to mouse Chromosome 11 is predominantly expressed in upper gastrointestinal tract but significantly suppressed in human gastric cancer cells. Mamm Genome. 11 (9): 718–724. https://doi.org/10.1007/s003350010138.CrossRefPubMed

24.

Carl-McGrath, S., R. Schneider-Stock, M. Ebert, and C. Röcken. 2008 Jan. Differential expression and localisation of gasdermin-like (GSDML), a novel member of the cancer-associated GSDMDC protein family, in neoplastic and non-neoplastic gastric, hepatic, and colon tissues. Pathology. 40 (1): 13–24. https://doi.org/10.1080/00313020701716250.CrossRefPubMed

25.

Sun Q, Yang J, Xing G, Sun Q, Zhang L, He F. Expression of GSDML associates with tumor progression in uterine cervix cancer. Transl Oncol. 2008 Jul;1(2):73-83. doi: https://doi.org/10.1593/tlo.08112. PMID: 18633457; PMCID: PMC2510814.

26.

Hergueta-Redondo M, Sarrió D, Molina-Crespo Á, Megias D, Mota A, Rojo-Sebastian A, García-Sanz P, Morales S, Abril S, Cano A, Peinado H, Moreno-Bueno G. Gasdermin-B promotes invasion and metastasis in breast cancer cells. PLoS One. 2014 Mar 27;9(3):e90099. doi: https://doi.org/10.1371/journal.pone.0090099. PMID: 24675552; PMCID: PMC3967990.

27.

Watabe K, Ito A, Asada H, Endo Y, Kobayashi T, Nakamoto K, Itami S, Takao S, Shinomura Y, Aikou T, Yoshikawa K, Matsuzawa Y, Kitamura Y, Nojima H. Structure, expression and chromosome mapping of MLZE, a novel gene which is preferentially expressed in metastatic melanoma cells. Jpn J Cancer Res. 2001 Feb;92(2):140-51. doi: https://doi.org/10.1111/j.1349-7006.2001.tb01076.x. PMID: 11223543; PMCID: PMC5926699.

28.

Saeki, N., T. Usui, K. Aoyagi, D.H. Kim, M. Sato, T. Mabuchi, K. Yanagihara, K. Ogawa, H. Sakamoto, T. Yoshida, and H. Sasaki. 2009 Mar. Distinctive expression and function of four GSDM family genes (GSDMA-D) in normal and malignant upper gastrointestinal epithelium. Genes Chromosomes Cancer. 48 (3): 261–271. https://doi.org/10.1002/gcc.20636.CrossRefPubMed

29.

Miguchi M, Hinoi T, Shimomura M, Adachi T, Saito Y, Niitsu H, Kochi M, Sada H, Sotomaru Y, Ikenoue T, Shigeyasu K, Tanakaya K, Kitadai Y, Sentani K, Oue N, Yasui W, Ohdan H. Gasdermin C is upregulated by inactivation of transforming growth factor β receptor type II in the presence of mutated Apc, promoting colorectal cancer proliferation. PLoS One. 2016 Nov 11;11(11):e0166422. doi: https://doi.org/10.1371/journal.pone.0166422. PMID: 27835699; PMCID: PMC5105946.

30.

Zhang Z, Zhang Y, Xia S, Kong Q, Li S, Liu X, Junqueira C, Meza-Sosa KF, Mok TMY, Ansara J, Sengupta S, Yao Y, Wu H, Lieberman J. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020 Mar;579(7799):415-420. doi: https://doi.org/10.1038/s41586-020-2071-9. Epub 2020 Mar 11. PMID: 32188940; PMCID: PMC7123794.

31.

Zhou Z, He H, Wang K, Shi X, Wang Y, Su Y, Wang Y, Li D, Liu W, Zhang Y, Shen L, Han W, Shen L, Ding J, Shao F. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science. 2020 May 29;368(6494):eaaz7548. doi: https://doi.org/10.1126/science.aaz7548. Epub 2020 Apr 16.

32.

Kayagaki, N., O.S. Kornfeld, B.L. Lee, I.B. Stowe, K. O’Rourke, Q. Li, W. Sandoval, D. Yan, J. Kang, M. Xu, J. Zhang, W.P. Lee, B.S. McKenzie, G. Ulas, J. Payandeh, M. Roose-Girma, Z. Modrusan, R. Reja, M. Sagolla, J.D. Webster, V. Cho, T.D. Andrews, L.X. Morris, L.A. Miosge, C.C. Goodnow, E.M. Bertram, and V.M. Dixit. 2021 Mar. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature. 591 (7848): 131–136. https://doi.org/10.1038/s41586-021-03218-7.CrossRefPubMed

33.

Wang, Y., and F. Shao. 2021 Apr 1. NINJ1, rupturing swollen membranes for cataclysmic cell lysis. Mol Cell. 81 (7): 1370–1371. https://doi.org/10.1016/j.molcel.2021.03.005.CrossRefPubMed

34.

Qiao, L., X. Wu, J. Zhang, L. Liu, X. Sui, R. Zhang, W. Liu, F. Shen, Y. Sun, and X. Xi. 2019 Nov. α-NETA induces pyroptosis of epithelial ovarian cancer cells through the GSDMD/caspase-4 pathway. FASEB J. 33 (11): 12760–12767. https://doi.org/10.1096/fj.201900483RR.CrossRefPubMed

35.

Yoshihara, K., A. Tajima, D. Komata, T. Yamamoto, S. Kodama, H. Fujiwara, M. Suzuki, Y. Onishi, M. Hatae, K. Sueyoshi, H. Fujiwara, Y. Kudo, I. Inoue, and K. Tanaka. 2009 Aug. Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis. Cancer Sci. 100 (8): 1421–1428. https://doi.org/10.1111/j.1349-7006.2009.01204.x.CrossRefPubMed

36.

Mok SC, Bonome T, Vathipadiekal V, Bell A, Johnson ME, Wong KK, Park DC, Hao K, Yip DK, Donninger H, Ozbun L, Samimi G, Brady J, Randonovich M, Pise-Masison CA, Barrett JC, Wong WH, Welch WR, Berkowitz RS, Birrer MJ. A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell. 2009 Dec 8;16(6):521-32. doi: https://doi.org/10.1016/j.ccr.2009.10.018. PMID: 19962670; PMCID: PMC3008560.

37.

Bonome T, Levine DA, Shih J, Randonovich M, Pise-Masison CA, Bogomolniy F, Ozbun L, Brady J, Barrett JC, Boyd J, Birrer MJ. A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. Cancer Res. 2008 Jul 1;68(13):5478-86. doi: https://doi.org/10.1158/0008-5472.CAN-07-6595. PMID: 18593951; PMCID: PMC7039050.

38.

Vathipadiekal, V., V. Wang, W. Wei, L. Waldron, R. Drapkin, M. Gillette, S. Skates, and M. Birrer. 2015 Nov 1. Creation of a human secretome: a novel composite library of human secreted proteins: validation using ovarian cancer gene expression data and a virtual secretome array. Clin Cancer Res. 21 (21): 4960–4969. https://doi.org/10.1158/1078-0432.CCR-14-3173.CrossRefPubMed

39.

Hendrix, N.D., R. Wu, R. Kuick, D.R. Schwartz, E.R. Fearon, and K.R. Cho. 2006 Feb 1. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res. 66 (3): 1354–1362. https://doi.org/10.1158/0008-5472.CAN-05-3694.CrossRefPubMed

40.

Wu R, Zhai Y, Kuick R, Karnezis AN, Garcia P, Naseem A, Hu TC, Fearon ER, Cho KR. Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse. J Pathol. 2016 Nov;240(3):341-351. doi: https://doi.org/10.1002/path.4783. PMID: 27538791; PMCID: PMC5071155.

41.

Karlan, B.Y., J. Dering, C. Walsh, S. Orsulic, J. Lester, L.A. Anderson, C.L. Ginther, M. Fejzo, and D. Slamon. 2014 Feb. POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer. Gynecol Oncol. 132 (2): 334–342. https://doi.org/10.1016/j.ygyno.2013.12.021.CrossRefPubMed

42.

Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 29;474(7353):609-15. doi: https://doi.org/10.1038/nature10166. Erratum in: Nature. 2012 Oct 11;490(7419):298. PMID: 21720365; PMCID: PMC3163504.

43.

Ganzfried BF, Riester M, Haibe-Kains B, Risch T, Tyekucheva S, Jazic I, Wang XV, Ahmadifar M, Birrer MJ, Parmigiani G, Huttenhower C, Waldron L. curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome. Database (Oxford). 2013 Apr 2;2013:bat013. doi: https://doi.org/10.1093/database/bat013. PMID: 23550061; PMCID: PMC3625954.

44.

Huber W, Carey VJ, Gentleman R, Anders S, Carlson M, Carvalho BS, Bravo HC, Davis S, Gatto L, Girke T, Gottardo R, Hahne F, Hansen KD, Irizarry RA, Lawrence M, Love MI, MacDonald J, Obenchain V, Oleś AK, Pagès H, Reyes A, Shannon P, Smyth GK, Tenenbaum D, Waldron L, Morgan M. Orchestrating high-throughput genomic analysis with Bioconductor. Nat Methods. 2015 Feb;12(2):115-21. doi: https://doi.org/10.1038/nmeth.3252. PMID: 25633503; PMCID: PMC4509590.

45.

Grossman RL, Heath AP, Ferretti V, Varmus HE, Lowy DR, Kibbe WA, Staudt LM. Toward a shared vision for cancer genomic data. N Engl J Med. 2016 Sep 22;375(12):1109-12. doi: https://doi.org/10.1056/NEJMp1607591. PMID: 27653561; PMCID: PMC6309165.

46.

Gyorffy, B., A. Lánczky, and Z. Szállási. 2012 Apr 10. Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. Endocr Relat Cancer. 19 (2): 197–208. https://doi.org/10.1530/ERC-11-0329.CrossRefPubMed

47.

Core Team, R. 2020. R: a language and environment for statistical computing. In R Foundation for Statistical Computing. Vienna: Austria. URL https://www.R-project.org/.

48.

Wickham, et al. 2019. Welcome to the tidyverse. Journal of Open Source Software 4 (43): 1686. https://doi.org/10.21105/joss.CrossRef

49.

Hadley Wickham and Jennifer Bryan (2019) readxl: Read Excel Files. R package version 1.3.1. https://CRAN.R-project.org/

50.

Jeroen Ooms (2020). magick: advanced graphics and image-processing in R. R package version 2.5.2. https://CRAN.R-project.org/

51.

Alboukadel Kassambara (2020). ggpubr: ‘ggplot2’ Based Publication Ready Plots. R package version 0.4.0. https://CRAN.R-project.org/

52.

Silge J, Robinson D (2016). “tidytext: text mining and analysis using tidy data principles in R.” JOSS, 1(3). doi: https://doi.org/10.21105/joss.00037.

53.

Schloerke, Barret, Di Cook, Joseph Larmarange, Francois Briatte, Moritz Marbach, Edwin Thoen, Amos Elberg, and Jason Crowley. 2021. GGally: extension to ‘ggplot2’. R package version 2 (1): 1 https://CRAN.R-project.org/.

54.

JJ Allaire and Yihui Xie and Jonathan McPherson and Javier Luraschi and Kevin Ushey and Aron Atkins and Hadley Wickham and Joe Cheng and Winston Chang and Richard Iannone (2020). rmarkdown: dynamic documents for R. R package version 2.6. https://rmarkdown.rstudio.com.

55.

Yihui Xie (2020). knitr: a general-purpose package for dynamic report generation in R. R package version 1.30.

56.

Baptiste Auguie (2017). gridExtra: miscellaneous functions for “Grid” graphics. R package version 2.3. https://CRAN.R-project.org/package=gridExtra

57.

Kersey PJ, Allen JE, Allot A, Barba M, Boddu S, Bolt BJ, Carvalho-Silva D, Christensen M, Davis P, Grabmueller C, Kumar N, Liu Z, Maurel T, Moore B, McDowall MD, Maheswari U, Naamati G, Newman V, Ong CK, Paulini M, Pedro H, Perry E, Russell M, Sparrow H, Tapanari E, Taylor K, Vullo A, Williams G, Zadissia A, Olson A, Stein J, Wei S, Tello-Ruiz M, Ware D, Luciani A, Potter S, Finn RD, Urban M, Hammond-Kosack KE, Bolser DM, De Silva N, Howe KL, Langridge N, Maslen G, Staines DM, Yates A. Ensembl Genomes 2018: an integrated omics infrastructure for non-vertebrate species. Nucleic Acids Res. 2018 Jan 4;46(D1):D802-D808. https://doi.org/10.1093/nar/gkx1011. PMID: 29092050; PMCID: PMC5753204.

58.

Zerbino DR, Achuthan P, Akanni W, Amode MR, Barrell D, Bhai J, Billis K, Cummins C, Gall A, Girón CG, Gil L, Gordon L, Haggerty L, Haskell E, Hourlier T, Izuogu OG, Janacek SH, Juettemann T, To JK, Laird MR, Lavidas I, Liu Z, Loveland JE, Maurel T, McLaren W, Moore B, Mudge J, Murphy DN, Newman V, Nuhn M, Ogeh D, Ong CK, Parker A, Patricio M, Riat HS, Schuilenburg H, Sheppard D, Sparrow H, Taylor K, Thormann A, Vullo A, Walts B, Zadissa A, Frankish A, Hunt SE, Kostadima M, Langridge N, Martin FJ, Muffato M, Perry E, Ruffier M, Staines DM, Trevanion SJ, Aken BL, Cunningham F, Yates A, Flicek P. Ensembl 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761. https://doi.org/10.1093/nar/gkx1098. PMID: 29155950; PMCID: PMC5753206.

59.

Jiang S, Zhou Z, Sun Y, Zhang T, Sun L. Coral gasdermin triggers pyroptosis. Sci Immunol. 2020 Dec 4;5(54):eabd2591. https://doi.org/10.1126/sciimmunol.abd2591.

60.

Berkel C, Cacan E. GAB2 and GAB3 are expressed in a tumor stage-, grade- and histotype-dependent manner and are associated with shorter progression-free survival in ovarian cancer. J Cell Commun Signal. 2021 Mar;15(1):57-70. https://doi.org/10.1007/s12079-020-00582-3. Epub 2020 Sep 4. PMID: 32888136; PMCID: PMC7904992.

61.

Broz, P., and V.M. Dixit. 2016 Jul. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 16 (7): 407–420. https://doi.org/10.1038/nri.2016.58.CrossRefPubMed

62.

Gao J, Qiu X, Xi G, Liu H, Zhang F, Lv T, Song Y. Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non-small cell lung cancer. Oncol Rep. 2018 Oct;40(4):1971-1984. https://doi.org/10.3892/or.2018.6634. Epub 2018 Aug 7. PMID: 30106450; PMCID: PMC6111570.

63.

Taabazuing CY, Okondo MC, Bachovchin DA. Pyroptosis and apoptosis pathways engage in bidirectional crosstalk in monocytes and macrophages. Cell Chem Biol. 2017 Apr 20;24(4):507-514.e4. https://doi.org/10.1016/j.chembiol.2017.03.009. Epub 2017 Apr 6. PMID: 28392147; PMCID: PMC5467448.

64.

Akino, K., M. Toyota, H. Suzuki, T. Imai, R. Maruyama, M. Kusano, N. Nishikawa, Y. Watanabe, Y. Sasaki, T. Abe, E. Yamamoto, I. Tarasawa, T. Sonoda, M. Mori, K. Imai, Y. Shinomura, and T. Tokino. 2007 Jan. Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer. Cancer Sci. 98 (1): 88–95. https://doi.org/10.1111/j.1349-7006.2006.00351.x.CrossRefPubMed

65.

Croes L, Beyens M, Fransen E, Ibrahim J, Vanden Berghe W, Suls A, Peeters M, Pauwels P, Van Camp G, Opde Beeck K. Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer. Clin Epigenetics. 2018 Apr 11;10:51. https://doi.org/10.1186/s13148-018-0479-y. PMID: 29682089; PMCID: PMC5896072.

66.

Croes L, de Beeck KO, Pauwels P, Vanden Berghe W, Peeters M, Fransen E, Van Camp G. DFNA5 promoter methylation a marker for breast tumorigenesis. Oncotarget. 2017 May 9;8(19):31948-31958. https://doi.org/10.18632/oncotarget.16654. PMID: 28404884; PMCID: PMC5458261.

67.

Kim MS, Lebron C, Nagpal JK, Chae YK, Chang X, Huang Y, Chuang T, Yamashita K, Trink B, Ratovitski EA, Califano JA, Sidransky D. Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer. Biochem Biophys Res Commun. 2008 May 23;370(1):38-43. https://doi.org/10.1016/j.bbrc.2008.03.026. Epub 2008 Mar 17. PMID: 18346456; PMCID: PMC3094717.

68.

Ibrahim J, Opde Beeck K, Fransen E, Croes L, Beyens M, Suls A, Vanden Berghe W, Peeters M, Van Camp G. Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer. Cancer Med. 2019 May;8(5):2133-2145. https://doi.org/10.1002/cam4.2103. Epub 2019 Apr 16. PMID: 30993897; PMCID: PMC6536921.

69.

Yokomizo, K., Y. Harada, K. Kijima, K. Shinmura, M. Sakata, K. Sakuraba, Y. Kitamura, A. Shirahata, T. Goto, H. Mizukami, M. Saito, G. Kigawa, H. Nemoto, and K. Hibi. 2012 Apr. Methylation of the DFNA5 gene is frequently detected in colorectal cancer. Anticancer Res. 32 (4): 1319–1322.PubMed

70.

Kim, M.S., X. Chang, K. Yamashita, J.K. Nagpal, J.H. Baek, G. Wu, B. Trink, E.A. Ratovitski, M. Mori, and D. Sidransky. 2008 Jun 5. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma. Oncogene. 27 (25): 3624–3634. https://doi.org/10.1038/sj.onc.1211021.CrossRefPubMed

Title: Differential Expression and Copy Number Variation of Gasdermin (GSDM) Family Members, Pore-Forming Proteins in Pyroptosis, in Normal and Malignant Serous Ovarian Tissue
Authors: Caglar Berkel
Ercan Cacan
Publication date: 01-12-2021
Publisher: Springer US
Keywords: Ovarian Cancer
Ovarian Cancer
Published in: Inflammation / Issue 6/2021
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-021-01493-0

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Differential Expression and Copy Number Variation of Gasdermin (GSDM) Family Members, Pore-Forming Proteins in Pyroptosis, in Normal and Malignant Serous Ovarian Tissue

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2021

Neuroprotective Effect of Plasminogen Activator Inhibitor-1 Antagonist in the Rat Model of Mild Traumatic Brain Injury

Anti-inflammatory and Antioxidant Effects of Rosuvastatin on Asthmatic, Hyperlipidemic, and Asthmatic-Hyperlipidemic Rat Models

ATN-161 Ameliorates Ischemia/Reperfusion-induced Oxidative Stress, Fibro-inflammation, Mitochondrial damage, and Apoptosis-mediated Tight Junction Disruption in bEnd.3 Cells

miR-483-3p Promotes IL-33 Production from Fibroblast-Like Synoviocytes by Regulating ERK Signaling in Rheumatoid Arthritis

Effects of Recombinant IL-35-BCG on Treg/Th17 Cell Imbalance and Inflammatory Response in Asthmatic Newborn Mice Induced by RSV

Severe Acute Respiratory Syndrome Coronavirus 2: The Role of the Main Components of the Innate Immune System

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page